Shockwave Medical is a healthcare company specializing in the development of Intravascular Lithotripsy (IVL) technology to treat calcified cardiovascular disease. Their innovative platform is designed to safely and effectively modify calcium within arteries, making procedures more predictable and efficient. Shockwave Medical's product portfolio includes solutions for coronary and peripheral applications and aims to address various challenges associated with calcified occlusive disease. The company is committed to offering advanced treatment options for patients with aortic stenosis and other cardiovascular conditions, and it emphasizes education and clinical evidence to support its technologies.